- Product Details
- Description
- Additional information
- More Offers
Description
Background Information:
VX-702 is an orally bioavailable p38 MAP kinase inhibitor developed to treat inflammatory diseases.
Reference:
1. C. Ding, VX-702, a MAP kinase inhibitor for rheumatoid arthritis
and acute coronary syndrome, Current Opinion in Investigational Drugs,
2006 7:1020-1025.
APIM050260: VX-702
CAS No.: 479543-46-9.
Molecular Formula: C19H12F4N4O2.
Molecular Weight: 404.32.
Purity: > 99% (HPLC).
QC: LC/MS, 1HNMR, HPLC.
Solubility: Soluble in DMSO.
Storage: Store at 0°C (short term), -20°C (long term), desiccated.
Additional information
Ship from Country | USA |
---|---|
Size | 10 mg, 100 mg, 200 mg, 25 mg |
No more offers for this product!